TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Director Scott Farquhar Executes Stock Sales Under 10b5-1 Plan

Sentiment:

SEC Form 4


Director Scott Farquhar sold shares of Atlassian Corp (TEAM) on March 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 28, 2025, Scott Farquhar, a director and 10% owner of Atlassian Corp (TEAM), sold Class A Common Stock.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 14, 2024.
  • The transactions involved multiple sales at varying prices, with weighted-average prices reported for each block of shares sold.
  • The shares were sold indirectly through the Farquhar Family Trust, with Skip Enterprises Pty Limited acting as trustee.
  • The total number of shares sold was 7,948.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales under a pre-arranged plan, so the sentiment is neither positive nor negative.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to use 10b5-1 plans to sell shares over time to avoid accusations of trading on material non-public information.

Stakeholder Impact

  • The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates

DateDescription
02/14/2024Date of adoption of Rule 10b5-1 trading plan
03/28/2025Date of stock sale transactions
03/31/2025Date of signature on the Form 4 filing

Keywords

Form 4, Atlassian, Scott Farquhar, Stock Sale, Rule 10b5-1, Director, TEAM

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.